{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:46:31Z","timestamp":1792089991456,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11115-w","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:21:02Z","timestamp":1791177662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond reduced intake: tumor metabolism and immune dysregulation drive cancer-related malnutrition in head and neck squamous cell carcinoma (HNSCC)"],"prefix":"10.1007","volume":"34","author":[{"given":"Vincenzo","family":"Zurlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Pontone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Raffaella","family":"Rampetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"1","key":"11115_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11\u201348","journal-title":"Clin Nutr"},{"issue":"5","key":"11115_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495","journal-title":"Lancet Oncol"},{"key":"11115_CR3","doi-asserted-by":"crossref","unstructured":"Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition \u2013 a consensus report from the global clinical nutrition community. Clinical Nutrition. 2019.","DOI":"10.1016\/j.clnu.2019.02.033"},{"issue":"4","key":"11115_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.clnu.2013.06.012","volume":"32","author":"JAE Langius","year":"2013","unstructured":"Langius JAE, Zandbergen MC, Eerenstein SEJ et al (2013) Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving radiotherapy. Clin Nutr 32(4):671\u2013678","journal-title":"Clin Nutr"},{"key":"11115_CR5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"key":"11115_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.105","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH (2018) Cancer-associated cachexia. Lancet Oncol. https:\/\/doi.org\/10.1038\/nrdp.2017.105","journal-title":"Lancet Oncol"},{"issue":"11","key":"11115_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14(11):754\u2013762","journal-title":"Nat Rev Cancer"},{"issue":"5930","key":"11115_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033","journal-title":"Science"},{"issue":"3","key":"11115_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211\u2013218","journal-title":"Trends Biochem Sci"},{"key":"11115_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0021-9258(18)83822-4","volume":"81","author":"CF Cori","year":"1929","unstructured":"Cori CF, Cori GT (1929) Glycogen formation in the liver from d- and l-lactic acid. J Biol Chem 81:389\u2013403","journal-title":"J Biol Chem"},{"issue":"7516","key":"11115_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir S, White JP, Kleiner S et al (2014) Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513(7516):100\u2013104","journal-title":"Nature"},{"issue":"11","key":"11115_CR12","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc.2016.132","volume":"16","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF (2016) Mechanisms of metabolic dysfunction in cancer-associated cachexia. Nat Rev Cancer 16(11):754\u2013765","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"11115_CR13","first-page":"799","volume":"9","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ (2009) Mechanisms of cancer cachexia. Nat Rev Cancer 9(11):799\u2013809","journal-title":"Nat Rev Cancer"},{"key":"11115_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis RJ, Chandel NS (2020) We need to talk about the Warburg effect. Nat Metab 2:127\u2013129","journal-title":"Nat Metab"},{"key":"11115_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368","journal-title":"Science"},{"issue":"11","key":"11115_CR16","first-page":"695","volume":"15","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Arribas L (2018) Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Nat Rev Clin Oncol 15(11):695\u2013707","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"11115_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.clnu.2007.03.011","volume":"26","author":"RJE Skipworth","year":"2007","unstructured":"Skipworth RJE, Stewart GD, Dejong CHC, Preston T, Fearon KCH (2007) Pathophysiology of cancer cachexia: much more than host\u2013tumour interaction? Clin Nutr 26(6):667\u2013676","journal-title":"Clin Nutr"},{"issue":"3","key":"11115_CR18","first-page":"378","volume":"40","author":"CSD Roxburgh","year":"2014","unstructured":"Roxburgh CSD, McMillan DC (2014) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Cancer Treat Rev 40(3):378\u2013386","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"11115_CR19","first-page":"976","volume":"126","author":"A Bonetto","year":"2016","unstructured":"Bonetto A, Aydogdu T, Kunzevitzky N et al (2016) STAT3 activation in skeletal muscle links muscle wasting to cancer cachexia. J Clin Investig 126(3):976\u2013990","journal-title":"J Clin Investig"},{"key":"11115_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","volume":"127","author":"J McGovern","year":"2022","unstructured":"McGovern J, Dolan RD, Skipworth RJS, Laird BJ, McMillan DC (2022) Cancer cachexia: a nutritional or a systemic inflammatory syndrome? Br J Cancer 127:379\u2013382","journal-title":"Br J Cancer"},{"key":"11115_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01167-9","author":"M Berriel Diaz","year":"2024","unstructured":"Berriel Diaz M, Rohm M, Herzig S (2024) Cancer cachexia: multilevel metabolic dysfunction. Nat Metab. https:\/\/doi.org\/10.1038\/s42255-024-01167-9","journal-title":"Nat Metab"},{"issue":"4","key":"11115_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J et al (2010) Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142(4):531\u2013543","journal-title":"Cell"},{"issue":"1","key":"11115_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331","journal-title":"Age Ageing"},{"key":"11115_CR24","volume":"15","author":"X Lin","year":"2024","unstructured":"Lin X, Deng L, Liang F, Han P, Lin P, Huang X (2024) Enhancing CD4+\/CD8+ T cell ratio and accelerating recovery in HNSCC patients through immunonutrition intervention. Discov Oncol 15","journal-title":"Discov Oncol"},{"key":"11115_CR25","first-page":"38","volume":"52","author":"Y Takenaka","year":"2016","unstructured":"Takenaka Y, Oya R, Takemoto N et al (2016) Prognostic impact of sarcopenia in patients with head and neck cancer: a meta-analysis. Oral Oncol 52:38\u201344","journal-title":"Oral Oncol"},{"issue":"12","key":"11115_CR26","first-page":"1140","volume":"142","author":"AJ Grossberg","year":"2016","unstructured":"Grossberg AJ, Chamchod S, Fuller CD et al (2016) Association of sarcopenia with toxicity and survival in patients with head and neck cancer receiving chemoradiotherapy. JAMA Otolaryngol-Head Neck Surg 142(12):1140\u20131148","journal-title":"JAMA Otolaryngol-Head Neck Surg"},{"key":"11115_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar SS, Williams GR, Muss HB, Nishijima TF (2016) Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis. Eur J Cancer 57:58\u201367","journal-title":"Eur J Cancer"},{"issue":"7","key":"11115_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CMM Prado","year":"2008","unstructured":"Prado CMM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours. Lancet Oncology 9(7):629\u2013635","journal-title":"Lancet Oncology"},{"issue":"3","key":"11115_CR29","first-page":"305","volume":"16","author":"VE Baracos","year":"2013","unstructured":"Baracos VE, Kazemi-Bajestani SMR (2013) Clinical outcomes related to muscle mass in cancer patients. Curr Opin Clin Nutr Metab Care 16(3):305\u2013311","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"11115_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","volume":"62","author":"JE Swartz","year":"2016","unstructured":"Swartz JE, Pothen AJ, Wegner I et al (2016) Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol 62:28\u201333","journal-title":"Oral Oncol"},{"issue":"2","key":"11115_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00259-014-2903-7","volume":"42","author":"HJ Im","year":"2015","unstructured":"Im HJ, Pak K, Cheon GJ et al (2015) Prognostic value of volumetric parameters of ^18F-FDG PET in non\u2013small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42(2):241\u2013251","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11115_CR32","unstructured":"Rey A, Perri F, Marciano ML, et al. Tumor metabolic activity correlates with skeletal muscle depletion and nutritional risk in patients with head and neck squamous cell carcinoma. Clinical Nutrition ESPEN. 2025 (in press)"},{"issue":"6","key":"11115_CR33","first-page":"902","volume":"70","author":"G Briuxola","year":"2018","unstructured":"Briuxola G, Cano D, Gomez C et al (2018) Prognostic impact of the prognostic nutritional index in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Nutr Cancer 70(6):902\u2013909","journal-title":"Nutr Cancer"},{"issue":"5","key":"11115_CR34","first-page":"1456","volume":"43","author":"K Yamahara","year":"2021","unstructured":"Yamahara K, Itoh Y, Suzuki Y et al (2021) Combined assessment of nutritional and inflammatory status predicts survival outcomes in patients with head and neck cancer. Head Neck 43(5):1456\u20131464","journal-title":"Head Neck"},{"issue":"5","key":"11115_CR35","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/nu12051340","volume":"12","author":"DC Ling","year":"2020","unstructured":"Ling DC, Smith GL, Amini A et al (2020) Prognostic role of the prognostic nutritional index and inflammatory biomarkers in patients with locally advanced head and neck cancer treated with concurrent chemoradiotherapy. Nutrients 12(5):1340","journal-title":"Nutrients"},{"key":"11115_CR36","first-page":"106320","volume":"138","author":"M Tomasoni","year":"2023","unstructured":"Tomasoni M, Resteghini C, Orlandi E et al (2023) Systemic immune-inflammatory indices as prognostic markers in locally advanced head and neck cancer undergoing chemoradiotherapy. Oral Oncol 138:106320","journal-title":"Oral Oncol"},{"key":"11115_CR37","unstructured":"De Ul\u00edbarri JI, Gonz\u00e1lez-Madro\u00f1o A, de Villar NG, Gonz\u00e1lez P, Gonz\u00e1lez B, Mancha A, Rodr\u00edguez F, Fern\u00e1ndez G (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr hosp 20(1):38-45"},{"issue":"1","key":"11115_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.radonc.2017.10.015","volume":"126","author":"E Cereda","year":"2018","unstructured":"Cereda E, Cappello S, Colombo S, Klersy C, Imarisio I, Turri A et al (2018) Nutritional counseling with or without systematic use of oral nutritional supplements in head and neck cancer patients undergoing radiotherapy. Radiother Oncol 126(1):81\u201388","journal-title":"Radiother Oncol"},{"issue":"5","key":"11115_CR39","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP et al (2017) ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 36(5):1187\u20131196","journal-title":"Clin Nutr"},{"issue":"7","key":"11115_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00520-009-0717-0","volume":"18","author":"A Paccagnella","year":"2010","unstructured":"Paccagnella A, Morello M, Da Mosto MC, Baruffi C, Marcon ML, Gava A et al (2010) Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing chemoradiotherapy. Support Care Cancer 18(7):837\u2013845","journal-title":"Support Care Cancer"},{"issue":"S1","key":"11115_CR41","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1017\/S0007114507832909","volume":"98","author":"PC Calder","year":"2007","unstructured":"Calder PC (2007) Immunonutrition in surgical and critically ill patients. Br J Nutr 98(S1):S133\u2013S139","journal-title":"Br J Nutr"},{"issue":"2","key":"11115_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KCH Fearon","year":"2012","unstructured":"Fearon KCH, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling and metabolic pathways. Cell Metab 16(2):153\u2013166","journal-title":"Cell Metab"},{"issue":"5","key":"11115_CR43","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","volume":"40","author":"M Muscaritoli","year":"2021","unstructured":"Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H et al (2021) ESPEN practical guideline: clinical nutrition in cancer. Clin Nutr 40(5):2898\u20132913","journal-title":"Clin Nutr"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11115-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11115-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11115-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:36Z","timestamp":1792086516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11115-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11115"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11115-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable because this study is based exclusively on published literature.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1056"}}